Have issue viewing this email? Click here
Issue no. 2, December 2021
We are excited to release our 2nd newsletter with you all! As you’ll discover soon enough, the consortium has been extremely active.

We closed year 1 of the 5-year Gravitate Health project in September, hosting a transition workshop for the entire consortium to highlight lessons learned and gains achieved. The COVID-19 pandemic forced us all to collaborate virtually, yet despite that, we remained strong and focused!

We were able to build user personas to help shape the design of the G-lens intervention so that patient centricity would become core from the very beginning.
We also fostered a more global presence, participating in various conferences that extended from Europe to Latin America to even Asia.

Here is a list of just some events where consortium partners underpinned the need for Gravitate Healths intervention in patient adherence and patient journey, as well as its potential contributions to overall healthcare:
AMPERES Conference (Latin America)
DIA Meetings: DIA Pharmacovigilance Strategies Workshop; DIA Japan; and DIA Japan Electronic Patient Information (ePI) Forum

As we lead into year 2, Gravitate Health will undertake more activities and actions to get us closer to achieving our mission. This includes participating in the HL7® FHIR® Connectathons held three times per year with the support of real use cases and ePI, and initiating engagement with health ecosystems from around the world (to be highlighted in our “Getting to Know Gravitate Health" interview below).

Curious to see how else the consortium is driving impactful, sustainable changes? Keep on reading below!

Gravitate Health is a unique public-private partnership with members from Europe and the U.S. collaborating on improving patient outcomes iteratively by equipping them with the right tools. Project and Coordination Leads Giovanna Ferrari (Pfizer) and Anne Moen (University of Oslo) share more details about the project in this exclusive interview with Healthcare Information and Management Systems Society (HIMSS).
Our Journey
Phase I of the Gravitate Health project has come to a finish! Phase 2 now marks the opportunity to apply an iterative, stepwise approach to developing FOSPS and G-lens services.

With the latter, Gravitate Health will aim to:
Refine requirements
Assess mock-ups and prototypes with G-lens, focusing on health information from trusted sources like SmPC, PIL and possibly HEM.

At the same time,
Gravitate Health will use HL7® FHIR® Connectathons to help achieve these aims. The project already participated in its very first in September 2021, gaining valuable insights that would contribute to the design of the G-lens (see below).

Finally, we at Gravitate Health have identified how communications and dissemination (CD) actions hold great potential to help the project meet sustainability aims. The CD activities play a key role in boosting stakeholder engagement, thereby facilitating effective and lasting acceptance and buy-in of project outcomes by all relevant internal and external stakeholders.

Represented by the triangular framework below, various consortium members from across different areas of expertise and focus will cooperate more closely together to build a more formidable business case of the project’s proposed digital intervention.

Gravitate Health Transitions into Year 2
Keeping The Patient as The Primary Focus
The paper inserts that come with medicine packets are notoriously user-unfriendly. The information available online can be confusing and sometimes even dangerous. How then can people find information fitted to their own circumstances and judge which sources are reliable?

In this article, you’ll read how
Gravitate Health started the year with momentum and conceived well-defined personas to help support the development of G-lens, open-source software to enhance the patient information journey.
Knowledge Pill - What Inspires Our Work?
This past September, Gravitate Health participated in the HL7® FHIR® Connectathon that hosted the Vulcan Accelerator track dedicated to electronic product information (ePI).
What did the Connectathon aim to achieve?
This particular track focused on:
Gave feedback on draft implementation guide, testing scenarios, sample data and the European Medicines Agency’s ePI specifications
Shedding light on international patient summary (IPS) and ePI topic areas
Exploring potential solutions for healthcare challenges
Who participated (although not limited to)?
— App developers, electronic health record vendors, business developers and software engineers
— European Medicines Agency
Why was this Connectathon important for Gravitate Health?
The Gravitate Health project, under the Innovative Medicines Initiative, explores how to use the ePI standard in conjunction with HL7® FHIR® IPS and other services such as those under myHealth@EU or EMA’s own SPOR implementation of ISO IDMP to increase access, understanding, adherence and safe use of medications.

This Connectathon

Provided the project with resources and accessibility to sample data and EMA’s ePI API and server so participants could envision real-world application of their work
Showcased the need and use case for structured dosing information and underpin the potential of Gravitate Health's digital intervention
Delivered insights about what areas to develop and strengthen when designed a patient-centred digital solution like G-lens.
Was this the only Connectathon for Gravitate Health?
No! Gravitate Health will join Connectathons three times per year until project completion. However, to make these events truly support an effective design of the G-lens, we need the insights and contributions of various profiles.
Learn more here to see if the next one in January 2022 is the right fit for you!
Latest News
Check out the most recent news of and advances made by Gravitate Health below!
A lot is happening, and you won’t want to miss it!
Save The Date!

Join the HL7 29th FHIR Connectathon: ePI Track Phase 2. 10-12 January 2022.

Year 1 Project Deliverables

Explore all deliverables from Gravitate Health during 2020-2021.
Two-Project Partnership

Discover how EU-funded projects are making a difference, together.

Upcoming Events
Engage with Us
Do you have recent initiatives or exciting content on our areas of interest you wish to share?

Send an email to the Gravitate Health team. We'd be happy to publish a selection of your contributions on our next newsletter or on the project's website!

Subscribe to Our Newsletter
Last but not least...
Supported by
Gravitate Health is an EU funded project which has received funding from the Innovative Medicines Initiative (IMI) with support from Horizon 2020 programme, the European Federation of Pharmaceutical Industries and Associations (EFPIA) and IMI2 Associated Partner Datapharm Ltd.

This communication reflects the views of the authors and neither the IMI nor the European Union, EFPIA, or Datapharm Limited are liable for any use that may be made of the information contained herein.

Gravitate Health under the lens - Issue no. 2, Dec. 2021
Follow Us
University of Oslo, Coordinator for Gravitate Health
Forskningsveien 2B
0373 Oslo

Copyright Νοtice | Privacy Policy